PLC Systems, Edwards amend Optiwave deal
This article was originally published in Clinica
Executive Summary
PLC Systems could gain up to $3.2m as a result of an amendment to an agreement with Edwards Lifesciences for the commercialisation of the latter's Optiwave 980 cardiac laser ablation technology.